|
시장보고서
상품코드
2108987
의료기기 포장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)Medical Device Packaging - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
의료기기 포장에는 무균 상태를 유지하고 물리적 손상 및 오염으로부터 보호하는 것은 물론, 제조부터 사용 현장에 이르기까지 의료기기의 안전하고 추적 가능한 운송, 보관, 취급을 가능하게 하는 1차, 2차, 3차 포장 시스템이 포함됩니다. 수술 기구나 임플란트부터 진단용 제품 및 소모품에 이르기까지, 의료기기는 사용 시점까지 무균 상태와 완벽한 상태를 유지해야 하므로, 의료기기 제조업체는 FDA의 고유 기기 식별(UDI) 요건, EU 의료기기 규정(MDR), ISO 11607의 무균 장벽 검증 등 엄격한 세계 규제 기준을 준수하는 검증 완료된 무균 장벽 시스템, 경질 트레이, 플렉서블 파우치 및 특수 라벨에 의존하고 있습니다. 본 시장은 포장 유형별(무균 포장 및 비무균 포장), 제품별(파우치·백, 트레이, 컨테이너, 박스·카톤, 병, 기타), 소재별(플라스틱, 종이 및 판지, 알루미늄 포일, 유리, 기타), 포장 기술별(열성형, 진공포장, 열밀봉, 냉간 성형, 기타)로 분류됩니다. 의료기기 유형별로는 진단 기기, 의료용 소모품, 수술 기구 및 이식형 의료기기가 주요 분야를 차지하고 있습니다. 또한, 최종 사용자별로는 의료기기 제조업체, 위탁 포장 업체, 수탁 제조업체 및 병원·의료시설 등이 포함됩니다. 수술 건수 증가, 전 세계적인 고령화, 전문 포장 파트너에 대한 아웃소싱 가속화, 그리고 업계 전반에 걸친 대규모 재편을 배경으로, 의료기기 포장은 전 세계 의료 시스템 전반에서 기기의 무균성, 환자 안전 및 공급망의 추적성을 보호하는 필수적인 인프라가 되고 있습니다.
의료기기 포장 시장의 주요 성장 동인
의료기기 포장 시장의 성장에 기여하는 요인
시장 성장 촉진요인
외과 수술 건수 및 일회용 의료기기 증가
의료기기 포장 시장의 가장 강력한 촉진요인은 전 세계적으로 지속적으로 증가하고 있는 외과 수술 건수와 일회용 의료기기입니다. 세계보건기구(WHO)의 추산에 따르면, 전 세계에서 매년 약 2억 3,400만 건의 대규모 외과 수술이 이루어지고 있으며, 각 수술에서 오염을 방지하고 환자의 안전을 확보하기 위해 기구, 임플란트 및 소모품용 검증된 무균 포장이 필요합니다. 감염 관리의 중요성이 높아지고 외래 및 당일 수술이 증가함에 따라 일회용 의료기기로의 전환이 가속화되면서, 재사용 가능한 의료기기 모델에 비해 포장 수요는 더욱 증가하고 있습니다. 저침습 수술 및 당일 퇴원 수술 건수가 계속 증가함에 따라, 신뢰성이 높은 무균 배리어 시스템에 대한 수요도 그에 비례하여 확대되고 있으며, 이는 2034년까지 시장 성장을 뒷받침하는 기반이 되고 있습니다.
대규모 업계 재편이 경쟁 구도를 재편하고 있습니다.
일련의 통합 움직임이 시장의 경쟁 구도를 재편하고 주요 공급업체의 규모를 확대시키고 있습니다. 암코어(Amcor plc)는 2025년, 베리 세계(Berry Global)을 84억 달러 규모의 전액 주식 교환 방식으로 인수를 완료했습니다. 이를 통해 약 140개국에 걸쳐 약 400개의 시설과 약 7만 명의 직원을 보유하며, 연간 매출액은 230억 달러에 달할 것으로 예상되는 헬스케어 전문 포장 그룹이 탄생했습니다. 2028 회계연도까지 6억 5,000만 달러의 비용 시너지 달성을 목표로 하고 있습니다. 이번 통합에 더해, 소노코(Sonoco)가 열성형 및 연포장 사업을 18억 달러에 토판(Toppan)에 매각하고, 고성장 퍼포먼스 허브로 자본을 재분배한 것은 규모, 규제 대응의 폭, 그리고 포트폴리오 집중이 얼마나 결정적인 경쟁 우위로 자리 잡고 있는지를 보여줍니다. 통합형 기업들이 헬스케어 포장 분야에서의 사업 기반을 확대함에 따라, 밸류체인 전반에 걸친 경쟁 심화와 서비스의 폭은 계속해서 확대되고 있습니다.
시장 제약 요인
강력한 성장세를 보이고 있음에도 불구하고, 의료기기 포장 시장은 중대한 제약에 직면해 있습니다. FDA의 UDI 규정, EU의 MDR에 기반한 무균 장벽 기준, ISO 11607의 검증 등 엄격하고 끊임없이 변화하는 규제 준수로 인해, 특히 신규 시장에 진입하는 중소 제조업체의 경우 인증까지의 기간이 길어지고 비용이 증가하고 있습니다. 클린룸 건설, ISO 13485 인증을 획득한 제조 시설, 그리고 특수 배리어 소재 생산에는 막대한 자본이 필요하며, 이는 진입 장벽이 되어 중소기업의 사업 확장을 제약하고 있습니다. 원자재 가격, 특히 의료용 플라스틱, 알루미늄 포일, 특수 필름의 가격 변동은 이익률을 압박하여 장기적인 가격 계약 체결을 어렵게 하고 있습니다. 일회용 플라스틱 포장을 둘러싼 환경 문제와 규제 당국의 감시 강화로 인해, 무균성을 저해하지 않으면서 재활용이 가능하고 단일 소재로 된 대체품을 개발해야 한다는 압박이 커지고 있으며, 많은 경우 비용이 많이 드는 재인증이 필요합니다. 배리어 필름, 타이벡, 특수 코팅용 복잡하고 다층적인 세계 공급망은 여전히 혼란의 영향을 받기 쉬운 상태입니다. 한편, 무균 배리어 검증에 정통한 포장 엔지니어의 부족이 생산 규모 확대를 제약하고 있습니다. 이러한 규제, 자본, 자재, 지속가능성 및 인력과 관련된 장벽들이 복합적으로 작용함에 따라, 수술 건수 증가, 아웃소싱, 업계 재편과 같은 근본적인 성장 요인들이 여전히 견조하게 유지되고 있음에도 불구하고 성장 속도는 둔화되고 있습니다.
Medical Device Packaging Market Summary
Medical device packaging encompasses the primary, secondary, and tertiary packaging systems that maintain sterility, protect against physical damage and contamination, and enable safe, traceable transport, storage, and handling of medical devices from manufacture to point of use. Because devices ranging from surgical instruments and implants to diagnostic and consumable products must remain sterile and intact until use, medical device manufacturers rely on validated sterile barrier systems, rigid trays, flexible pouches, and specialized labeling that comply with stringent global regulatory standards, including FDA Unique Device Identification (UDI) requirements, the EU Medical Device Regulation (MDR), and ISO 11607 sterile barrier validation. The market is organized by packaging type across sterile and non-sterile packaging; by product, including pouches & bags, trays, containers, boxes & cartons, bottles, and others; by material, spanning plastics, paper & paperboard, aluminum foil, glass, and others; by packaging technology, including thermoforming, vacuum packaging, heat sealing, cold forming, and others; by device type, led by diagnostic devices, medical consumables, surgical instruments, and implantable medical devices; and by end user, spanning medical device manufacturers, contract packaging organizations, contract manufacturing organizations, and hospitals & healthcare facilities. Driven by rising surgical volumes, an aging global population, accelerating outsourcing to specialized packaging partners, and sweeping industry consolidation, medical device packaging has become essential infrastructure safeguarding device sterility, patient safety, and supply-chain traceability across the global healthcare system.
Medical Device Packaging Market Key Growth Drivers
Key Companies in Medical Device Packaging Market
The competitive landscape is led by the following active manufacturers:
Factors Contributing to the Growth of the Medical Device Packaging Market
Market Drivers
Rising Volume of Surgical Procedures and Single-Use Medical Devices
The most powerful driver of the medical device packaging market is the sustained global rise in surgical procedures and single-use, disposable medical devices. The World Health Organization estimates that approximately 234 million major surgical procedures are performed worldwide each year, and each procedure requires validated sterile packaging for instruments, implants, and consumables to prevent contamination and ensure patient safety. The shift toward single-use devices, driven by infection-control priorities and outpatient and ambulatory surgical growth, further multiplies packaging volumes relative to reusable-device models. As minimally invasive procedures and same-day surgical volumes continue to expand, demand for high-integrity sterile barrier systems grows directly in step, anchoring market growth through 2034.
Large-Scale Industry Consolidation Reshaping Competitive Scale
A wave of consolidation is reshaping the competitive structure of the market and expanding the scale of leading providers. Amcor plc completed its USD 8.4 billion all-stock acquisition of Berry Global in 2025, creating a healthcare-focused packaging group spanning approximately 140 countries, roughly 400 facilities, about 70,000 employees, and USD 23 billion in anticipated annual sales, with a targeted USD 650 million in cost synergies by fiscal 2028. This combination, alongside Sonoco's divestiture of its thermoformed and flexibles operations to Toppan for USD 1.8 billion to redirect capital toward high-growth performance hubs, illustrates how scale, regulatory breadth, and portfolio focus are becoming decisive competitive advantages. As integrated players expand their healthcare packaging footprints, competitive intensity and service breadth across the value chain continue to increase.
Market Restraints
Despite strong momentum, the medical device packaging market faces material constraints. Stringent and evolving regulatory compliance across FDA UDI rules, EU MDR sterile barrier standards, and ISO 11607 validation lengthens qualification timelines and raises costs, particularly for smaller manufacturers entering new markets. The high capital intensity of cleanroom construction, ISO 13485-certified manufacturing, and specialized barrier-material production creates significant barriers to entry and constrains expansion among smaller players. Volatility in raw material prices, particularly for medical-grade plastics, aluminum foil, and specialty films, pressures margins and complicates long-term pricing agreements. Environmental concerns and regulatory scrutiny around single-use plastic packaging are increasing pressure to develop recyclable and monomaterial alternatives without compromising sterility assurance, often requiring costly requalification. Complex, multi-tier global supply chains for barrier films, Tyvek, and specialty coatings remain vulnerable to disruption, while a shortage of packaging engineers skilled in sterile barrier validation constrains scale-up. Together, these regulatory, capital, material, sustainability, and workforce barriers temper the pace of growth, even as the underlying drivers of surgical volume growth, outsourcing, and industry consolidation remain firmly intact.
Medical Device Packaging Market Segment Analysis
The medical device packaging by packaging type (sterile packaging and non-sterile packaging), product (pouches & bags, trays, containers, boxes & cartons, bottles, and others), material (plastics, paper & paperboard, aluminum foil, glass, and others), packaging technology (thermoforming, vacuum packaging, heat sealing, cold forming, and others), device type (diagnostic devices, medical consumables, surgical instruments, implantable medical devices, and others), end user (medical device manufacturers, contract packaging organizations, contract manufacturing organizations, hospitals & healthcare facilities, and others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).
By Packaging Type
Dominant Subsegment: Sterile Packaging.
The sterile packaging segment accounted for 58% of the medical device packaging market in 2025. Sterile packaging is the leading packaging type because the large majority of surgical instruments, implants, and single-use consumables must remain sterile from manufacture through point of use, requiring validated barrier systems produced under ISO Class 7 and ISO Class 8 cleanroom conditions. Rising surgical procedure volumes, growing adoption of single-use devices, and stringent FDA and EU MDR sterility-assurance requirements sustain large, recurring demand for validated sterile pouches, trays, and wraps. Providers such as Nelipak, Oliver Healthcare Packaging, and Coveris have expanded cleanroom capacity specifically to serve this segment. While non-sterile packaging, used for secondary and tertiary protection, distribution, and non-invasive devices, continues to grow steadily, the depth of regulatory requirements and clinical necessity underpinning sterile applications secure the segment's leadership across the forecast period.
By Product
Dominant Subsegment: Pouches & Bags.
The pouches & bags segment accounted for 36% of the medical device packaging market in 2025. Pouches and bags are the leading product category because they offer a favorable combination of flexibility, cost-efficiency, and compatibility with multiple sterilization methods, including ethylene oxide, gamma irradiation, and steam, making them the default choice for packaging a broad range of surgical instruments, consumables, and diagnostic products. Header bags, vented bags, and film bags are widely used across device classes, and their lightweight format reduces shipping and storage costs relative to rigid alternatives. Trays remain essential for protecting complex, high-value, and delicate devices requiring rigid support during handling and transport, and are growing quickly alongside minimally invasive surgical kits. Nonetheless, the versatility, cost advantage, and sheer breadth of applications served by pouches and bags secure the segment's leadership through 2034.
By Material
Dominant Subsegment: Plastics.
The plastics segment accounted for 62% of the medical device packaging market in 2025. Plastics, including polyethylene, polypropylene, and PVC, are the leading packaging material because of their lightweight profile, cost-effectiveness, design flexibility, and compatibility with thermoforming, sealing, and multiple sterilization methods. Plastic materials support a wide range of formats, including thermoformed blister trays, pouches, bottles, and clamshells, and are central to sterile barrier system design across surgical, diagnostic, and consumable device categories. Paper & paperboard is growing steadily as a sustainable, recyclable alternative for pouches and headerbags, while aluminum foil and glass serve specialized barrier and rigid-container applications. Sustainability pressure is accelerating adoption of monomaterial and recycled-content plastic films, exemplified by the Coveris-SABIC closed-loop initiative, but the performance advantages and processing versatility of plastics secure the segment's clear leadership across the forecast period.
Medical Device Packaging Market Region Analysis
Dominant Region: North America
North America accounted for 33% of the global medical device packaging market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a mature medical device manufacturing base, stringent FDA regulatory standards, high healthcare expenditure, and the concentrated presence of leading packaging providers, particularly in the United States. North America hosts substantial validated sterile barrier manufacturing capacity, and sponsors benefit from proximity to major converters, including DuPont, TekniPlex Healthcare, and Nelipak. Heavy investment is expanding capacity, including TekniPlex's new Madison, Wisconsin facility and Nelipak's Costa Rica expansion serving the broader North American and Caribbean footprint, while rising surgical volumes and single-use device adoption sustain outsourced packaging demand. Strong regulatory clarity, reimbursement infrastructure, and proximity to device OEMs anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the medical device packaging market. The region's elevated CAGR is driven by rapid expansion of medical device manufacturing, rising healthcare investment, and growing surgical volumes across China, Japan, India, South Korea, and Australia. China is scaling domestic device manufacturing and packaging capacity, Japan's aging population is driving diagnostic and implantable device demand, and India is emerging as a lower-cost manufacturing and packaging hub attracting global capacity investment, illustrated by Sonoco's redirection of capital toward high-growth performance hubs in India. Nelipak's new Asia-Pacific Technical Development Center in Singapore reflects the strategic importance of the region to global packaging providers. Government healthcare investment, expanding device manufacturing ecosystems, and rising regional demand for validated sterile packaging position Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 33% of the global medical device packaging market revenue in 2025. The United States dominates on the strength of its device manufacturing base, FDA regulatory clarity, and concentrated presence of leading packaging converters, while heavy investment in new cleanroom capacity and Amcor's newly expanded healthcare packaging scale following the Berry Global acquisition reinforce the region's leadership.
Europe
Europe is a large and advanced regional market, supported by a strong medical device manufacturing base, established EU MDR regulatory frameworks, and growing sustainable packaging capacity. Capacity investments such as Coveris's Rohrdorf and Halle site upgrades in Germany and DuPont's continued Tyvek innovation reinforce the region's role in supplying validated sterile and sustainable packaging across Germany, France, the United Kingdom, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rapid device manufacturing expansion, rising healthcare investment, and growing surgical and diagnostic volumes across China, Japan, India, South Korea, and Australia. Nelipak's new Singapore Technical Development Center and Sonoco's India-focused capital redirection are accelerating regional packaging capacity and capability build-out.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding medical device manufacturing and healthcare infrastructure, rising demand for sterile and traceable packaging, and efforts to align regulatory frameworks with global standards are gradually broadening access, while international partnerships and capacity investment, including Nelipak's continued Costa Rica expansion, support the build-out of regional capacity.
Medical Device Packaging Market Competitive Landscape
The medical device packaging market is classified as Fragmented. A group of large, diversified packaging groups with global scale and integrated manufacturing, including Amcor (following its 2025 acquisition of Berry Global), DuPont, and Sonoco, anchor the top tier, while specialized and fast-scaling healthcare-focused providers such as Nelipak, Oliver Healthcare Packaging, Wipak Group, TekniPlex Healthcare, Coveris Healthcare, and Sealed Air Corporation compete through cleanroom customization, sterile barrier expertise, and regional footprints, increasing competition across sterile packaging and specialty device segments.
The competitive landscape can be evaluated across the following dimensions:
Medical Device Packaging Market Recent Developmental Activities
In 2025, Amcor plc completed its USD 8.4 billion all-stock acquisition of Berry Global, creating a healthcare-focused packaging group spanning approximately 140 countries with roughly USD 23 billion in anticipated annual sales. Strategic significance: Establishes Amcor as an integrated global leader in healthcare and consumer packaging with substantial synergy targets.
In January 2026, Amcor plc completed the acquisition of a specialized medical film converter to expand production capacity for high-barrier thermoformed trays across European clinical hubs. Strategic significance: Strengthens Amcor's European sterile barrier trays capacity and clinical-market reach.
Medical Device Packaging Market Segmentation
Medical Device Packaging Market by Packaging Type
Medical Device Packaging Market by Product
Medical Device Packaging Market by Material
Medical Device Packaging Market by Packaging Technology
Medical Device Packaging Market by Device Type
Medical Device Packaging Market by End User
Medical Device Packaging Market by Geography
Key Takeaways from the Medical Device Packaging Market Report Study
Target audience who can benefit from this medical device packaging market report study
Q1. What is the growth rate of the medical device packaging market?
The medical device packaging market is projected to expand at a CAGR of 5.72% during the forecast period from 2026-2034.
Q2. What is the market size of the medical device packaging market?
The medical device packaging market is estimated at USD 28.40 billion in 2025 and is projected to reach USD 46.66 billion by 2034.
Q3. Which region dominates the medical device packaging market?
North America dominated the medical device packaging market with a 33% share of global revenue in 2025, supported by a mature device manufacturing base, stringent FDA regulatory standards, high healthcare expenditure, and the concentrated presence of leading packaging providers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the medical device packaging market?
The principal drivers are rising global surgical procedure volumes and single-use device adoption, with the World Health Organization estimating approximately 234 million major surgical procedures performed annually; large-scale industry consolidation, exemplified by Amcor's USD 8.4 billion acquisition of Berry Global; increasing outsourcing to contract packaging organizations; stringent regulatory and sterility-assurance requirements; and rising chronic disease burden and an aging global population.
Q5. Who are the major players in the medical device packaging market?
The major players include Amcor plc., Oliver Healthcare Packaging, Nelipak Healthcare Packaging, Wipak Group, DuPont, TekniPlex Healthcare, Berry Global Inc., Sonoco Products Company, Coveris Healthcare, and Sealed Air Corporation, among other active providers profiled in the Competitive Landscape section. Amcor, DuPont, and Sonoco lead through global scale and integrated manufacturing.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.